How is this different from large data-vendor outputs?
Large data-vendor outputs are often anchored in national prescription claims and structured publication databases. They tell you who currently prescribes at high volume. We focus on the harder question: who influences whom, and who is on the trajectory to matter in 18 months. We close the gaps standard datasets often miss, particularly where billing data is incomplete, in narrow indications, and in rising-star identification.
How long does an engagement take?
A typical KOL mapping engagement runs 6 to 10 weeks, depending on the indication scope, the size of the universe and the depth of profiling you need. Faster turnarounds are possible for narrow indications. National Champions should ideally be engaged 12 to 18 months ahead of approval, so the earlier you start, the more you get from the work.
Do you only work in Canada?
No. Our engagements span Canada, the United States and international biopharma. Canadian work uses Canadian data sources: provincial billing, CDA-AMC, pCPA and national society leadership. Global work uses the international equivalents. Therapeutic area and indication drive the method more than geography does.
What therapeutic areas do you work in?
Deep experience in oncology (hematologic and solid tumours), rare disease, immunology and specialty therapeutic areas where the influencer set is concentrated. We don’t do high-volume primary care KOL work. The method is designed for narrow specialties where every name matters.
What if we already have a list we like?
That’s usually the best place to start. We treat your list as a hypothesis, validate every name against the six-dimension framework, surface the names you’re missing, flag the names that no longer meet criteria (retirement, relocation, specialty drift) and tier the rest. You keep what’s right. We add what’s missing. We document what we changed and why.
What if our indication is so rare the universe is only 20 to 40 physicians globally?
The smaller the universe, the higher the cost of getting it wrong. Narrow universes are where multi-source identification pays for itself, because two or three missed names can change how a launch goes.
How do you handle data privacy and regulatory compliance?
All physician data comes from publicly available records, peer-reviewed publications, society and conference websites and government datasets. We don’t use prescription-level data without appropriate licensing, and we don’t include patient-level information. Deliverables are formatted to fit your internal compliance and privacy framework.
How do we get a quote?
Book the 30-minute call. We need 20 minutes to understand the indication, the launch window and the universe size. Then we can scope and price the engagement within 48 hours.
